MOESM3 of Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma

Additional file 3: Table S3. Correlation of PODXL score/expression between whole tissue sections and corresponding TMA cores from resected primary tumors.